Three and Four Courses of Radiation for Children with Recurrent Diffuse Intrinsic Pontine Glioma.

IF 2.4 3区 医学 Q2 HEMATOLOGY
Nisha Shariff, Anthony Lausch, Eric Bouffet, Derek S Tsang
{"title":"Three and Four Courses of Radiation for Children with Recurrent Diffuse Intrinsic Pontine Glioma.","authors":"Nisha Shariff, Anthony Lausch, Eric Bouffet, Derek S Tsang","doi":"10.1002/pbc.31695","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Re-irradiation (RT2) for children with diffuse intrinsic pontine glioma (DIPG) is increasingly used upon recurrence; however, limited data are available for evaluating additional courses of radiotherapy (RT) for DIPG. The purpose of this case series was to report our institutional experience in treating patients with recurrent DIPG with three (RT3) or four (RT4) courses of RT.</p><p><strong>Material and methods: </strong>A retrospective study of all children with DIPG treated with RT3 or RT4 at a single institution was performed. Medical records were reviewed, and composite dosimetry across all delivered courses of RT was reconstructed. All patients received conventionally fractionated photon RT at 1.8-2 Gy per day, with RT3 or RT4 dose prescriptions ranging 18-21.6 Gy in 10-12 fractions to the brainstem.</p><p><strong>Results: </strong>Five patients were identified; four received three courses of RT while one received four to the brainstem. Median survival from the last course of radiation to death was 4 months; median survival from the first course of RT was 26 months. The median cumulative brainstem D0.03cc for all courses of radiation was 104 Gy (interquartile range: 102-112 Gy). The median time from RT2 to RT3 was 8 months, with partial neurologic recovery (80%) or stable symptoms (20%) after RT3. Radiological appearance of tumor or brainstem necrosis was reported in two patients after RT3 (40%).</p><p><strong>Conclusions: </strong>A third course of RT may be carefully considered as a treatment option for selected children with recurrent DIPG to provide palliation of neurologic symptoms.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e31695"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pbc.31695","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Re-irradiation (RT2) for children with diffuse intrinsic pontine glioma (DIPG) is increasingly used upon recurrence; however, limited data are available for evaluating additional courses of radiotherapy (RT) for DIPG. The purpose of this case series was to report our institutional experience in treating patients with recurrent DIPG with three (RT3) or four (RT4) courses of RT.

Material and methods: A retrospective study of all children with DIPG treated with RT3 or RT4 at a single institution was performed. Medical records were reviewed, and composite dosimetry across all delivered courses of RT was reconstructed. All patients received conventionally fractionated photon RT at 1.8-2 Gy per day, with RT3 or RT4 dose prescriptions ranging 18-21.6 Gy in 10-12 fractions to the brainstem.

Results: Five patients were identified; four received three courses of RT while one received four to the brainstem. Median survival from the last course of radiation to death was 4 months; median survival from the first course of RT was 26 months. The median cumulative brainstem D0.03cc for all courses of radiation was 104 Gy (interquartile range: 102-112 Gy). The median time from RT2 to RT3 was 8 months, with partial neurologic recovery (80%) or stable symptoms (20%) after RT3. Radiological appearance of tumor or brainstem necrosis was reported in two patients after RT3 (40%).

Conclusions: A third course of RT may be carefully considered as a treatment option for selected children with recurrent DIPG to provide palliation of neurologic symptoms.

目的:越来越多的儿童弥漫性桥脑胶质瘤(DIPG)患者在复发后接受再次放疗(RT2)治疗;然而,评估DIPG额外放疗(RT)疗程的数据有限。本病例系列旨在报告我院对复发性DIPG患者进行三个(RT3)或四个(RT4)疗程RT治疗的经验:材料: 我们对在一家医疗机构接受 RT3 或 RT4 治疗的所有 DIPG 儿童进行了回顾性研究。对病历进行了审查,并重建了所有RT疗程的综合剂量测定。所有患者都接受了传统的分次光子 RT,每天 1.8-2 Gy,脑干的 RT3 或 RT4 剂量处方为 18-21.6 Gy,分 10-12 次进行:共发现五名患者,其中四人接受了三个疗程的 RT 治疗,一人接受了四个疗程的脑干 RT 治疗。从接受最后一个疗程的放射治疗到死亡的中位生存期为4个月;从接受第一个疗程的放射治疗到死亡的中位生存期为26个月。所有放射疗程的脑干D0.03cc累积中位数为104 Gy(四分位间范围:102-112 Gy)。从RT2到RT3的中位时间为8个月,RT3后神经系统部分恢复(80%)或症状稳定(20%)。RT3后有两名患者(40%)出现肿瘤或脑干坏死的放射学表现:结论:对于某些复发性DIPG患儿,可慎重考虑进行第三个疗程的RT治疗,以缓解神经症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信